Target intelligence / Profile preview

Lipocalin 1 pseudogene 2 (LCN1P2)

Target: LCN1P2
Molecular classification: Other (pseudogene)

Overview

Lipocalin 1 pseudogene 2 (LCN1P2) is a human pseudogene related in sequence to the functional lipocalin 1 (LCN1) gene. Unlike LCN1, which encodes an extracellular protein involved in binding and transporting hydrophobic molecules, LCN1P2 is classified as a pseudogene and does not produce a functional protein product[1][3]. As such, it does not have known biological activity, molecular function, disease associations, or roles as a therapeutic target.

Other names: bA244N20.11

Beyond the preview

Go deeper on Lipocalin 1 pseudogene 2 (LCN1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipocalin 1 pseudogene 2 (LCN1P2).

Explore the full profile